Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Jul 29

PMID 35903090

Authors

Yannan Shi

Ying-Zheng Zhao

Zhikai Jiang

Zeqing Wang

Qian Wang

Longfa Kou

Qing Yao

Affiliations

Soon will be listed here.

Abstract

Type 1 diabetes (T1D) is an autoimmune disease caused by the immune system attacking and destroying insulin-producing β cells in the pancreas. Islet transplantation is becoming one of the most promising therapies for T1D patients. However, its clinical use is limited by substantial cell loss after islet infusion, closely related to immune reactions, including instant blood-mediated inflammatory responses, oxidative stress, and direct autoimmune attack. Especially the grafted islets are not only exposed to allogeneic immune rejection after transplantation but are also subjected to an autoimmune process that caused the original disease. Due to the development and convergence of expertise in biomaterials, nanotechnology, and immunology, protective strategies are being investigated to address this issue, including exploring novel immune protective agents, encapsulating islets with biomaterials, and searching for alternative implantation sites, or co-transplantation with functional cells. These methods have significantly increased the survival rate and function of the transplanted islets. However, most studies are still limited to animal experiments and need further studies. In this review, we introduced the immunological challenges for islet graft and summarized the recent developments in immune-protective strategies to improve the outcomes of islet transplantation.

Citing Articles

The Insulin-Producing Cells Generated from Rat Adipose Tissue Mesenchymal Stem Cells via Pdx1 Overexpression Activate an Immune Response both and .

Mohammadian S, Hosseni S, Negad Dehbashi F, Dayer D Iran J Med Sci. 2025; 50(2):112-123.

PMID: 40026296 PMC: 11870862. DOI: 10.30476/ijms.2024.101162.3378.

Curcumin-loaded bioadhesive silk fibroin microsphere improves islet transplantation by mitigating oxidative stress and inhibiting apoptosis.

Yang C, Yu R, Zhang Y, Wang Q, Huang D, Cheng Y Mater Today Bio. 2025; 31:101507.

PMID: 39925714 PMC: 11804778. DOI: 10.1016/j.mtbio.2025.101507.

Advanced therapy to cure diabetes: mission impossible is now possible?.

Rohban R, Martins C, Esni F Front Cell Dev Biol. 2024; 12:1484859.

PMID: 39629270 PMC: 11611888. DOI: 10.3389/fcell.2024.1484859.

The Role of the Pancreatic Extracellular Matrix as a Tissue Engineering Support for the Bioartificial Pancreas.

Santos da Silva T, da Silva-Junior L, Horvath-Pereira B, Valbao M, Garcia M, Lopes J Biomimetics (Basel). 2024; 9(10).

PMID: 39451804 PMC: 11505355. DOI: 10.3390/biomimetics9100598.

Strategy for Clinical Setting of Co-transplantation of Mesenchymal Stem Cells and Pancreatic Islets.

Mei L, Yuwei Y, Weiping L, Zhiran X, Bingzheng F, Jibing C Cell Transplant. 2024; 33:9636897241259433.

PMID: 38877672 PMC: 11179456. DOI: 10.1177/09636897241259433.

References

Sudo T, Hiyama E, Murakami Y, Yokoyama Y, Takesue Y, Sueda T . Hepatic regeneration promotes engraftment of intraportally transplanted islet cells. Surgery. 2005; 137(6):612-9. DOI: 10.1016/j.surg.2005.02.007. View

Rajab A . Islet transplantation: alternative sites. Curr Diab Rep. 2010; 10(5):332-7. DOI: 10.1007/s11892-010-0130-6. View

Burke 3rd G, Vendrame F, Virdi S, Ciancio G, Chen L, Ruiz P . Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity. Curr Diab Rep. 2015; 15(12):121. DOI: 10.1007/s11892-015-0691-5. View

White A, Shamul J, Xu J, Stewart S, Bromberg J, He X . Engineering Strategies to Improve Islet Transplantation for Type 1 Diabetes Therapy. ACS Biomater Sci Eng. 2020; 6(5):2543-2562. PMC: 7720680. DOI: 10.1021/acsbiomaterials.9b01406. View

Lee S, Kim H, Byun N, Park C . Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment. Cell Transplant. 2020; 29:963689720913876. PMC: 7586274. DOI: 10.1177/0963689720913876. View

Wang L, Ernst A, Flanders J, Liu W, Wang X, Datta A . An inverse-breathing encapsulation system for cell delivery. Sci Adv. 2021; 7(20). PMC: 8121434. DOI: 10.1126/sciadv.abd5835. View

Weaver J, Headen D, Hunckler M, Coronel M, Stabler C, Garcia A . Design of a vascularized synthetic poly(ethylene glycol) macroencapsulation device for islet transplantation. Biomaterials. 2018; 172:54-65. PMC: 5967258. DOI: 10.1016/j.biomaterials.2018.04.047. View

Gou W, Wang J, Song L, Kim D, Cui W, Strange C . Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation. Am J Transplant. 2020; 21(5):1713-1724. PMC: 8082666. DOI: 10.1111/ajt.16342. View

Johansson H, Goto M, Dufrane D, Siegbahn A, Elgue G, Gianello P . Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant. 2006; 6(2):305-12. DOI: 10.1111/j.1600-6143.2005.01186.x. View

10.

Abdulreda M, Molano R, Faleo G, Lopez-Cabezas M, Shishido A, Ulissi U . In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice. Diabetologia. 2019; 62(7):1237-1250. PMC: 6561836. DOI: 10.1007/s00125-019-4879-0. View

11.

Gamble A, Pepper A, Bruni A, Shapiro A . The journey of islet cell transplantation and future development. Islets. 2018; 10(2):80-94. PMC: 5895174. DOI: 10.1080/19382014.2018.1428511. View

12.

Desai T, Shea L . Advances in islet encapsulation technologies. Nat Rev Drug Discov. 2016; 16(5):338-350. PMC: 11286215. DOI: 10.1038/nrd.2016.232. View

13.

Robertson S, Rowan-Hull A, Johnson P . The spleen--a potential source of new islets for transplantation?. J Pediatr Surg. 2008; 43(2):274-8. DOI: 10.1016/j.jpedsurg.2007.10.013. View

14.

KELLY W, Lillehei R, Merkel F, Idezuki Y, Goetz F . Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 1967; 61(6):827-37. View

15.

Ricci M, Blasi P, Giovagnoli S, Rossi C, Macchiarulo G, Luca G . Ketoprofen controlled release from composite microcapsules for cell encapsulation: effect on post-transplant acute inflammation. J Control Release. 2005; 107(3):395-407. DOI: 10.1016/j.jconrel.2005.06.023. View

16.

Kosinova L, Patikova A, Jirak D, Galisova A, Vojtiskova A, Saudek F . A novel model for quantification of immediate liver perfusion impairment after pancreatic islet transplantation. Islets. 2019; 11(6):129-140. PMC: 6930024. DOI: 10.1080/19382014.2019.1651164. View

17.

Addison P, Fatakhova K, Rodriguez Rilo H . Considerations for an Alternative Site of Islet Cell Transplantation. J Diabetes Sci Technol. 2019; 14(2):338-344. PMC: 7196852. DOI: 10.1177/1932296819868495. View

18.

Yao Q, Jiang X, Huang Z, Lan Q, Wang L, Chen R . Bilirubin Improves the Quality and Function of Hypothermic Preserved Islets by Its Antioxidative and Anti-inflammatory Effect. Transplantation. 2019; 103(12):2486-2496. DOI: 10.1097/TP.0000000000002882. View

19.

Zhao Y, Huang Z, Zhai Y, Shi Y, Du C, Zhai J . Polylysine-bilirubin conjugates maintain functional islets and promote M2 macrophage polarization. Acta Biomater. 2021; 122:172-185. DOI: 10.1016/j.actbio.2020.12.047. View

20.

Syed F, Bugliani M, Novelli M, Olimpico F, Suleiman M, Marselli L . Conformal coating by multilayer nano-encapsulation for the protection of human pancreatic islets: In-vitro and in-vivo studies. Nanomedicine. 2018; 14(7):2191-2203. DOI: 10.1016/j.nano.2018.06.013. View